Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="251752.fig.005a" src="https://static.hindawi.com/articles/bri/volume-2013/251752/figures/251752.fig.005a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Western blot analysis</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="251752.fig.005b" src="https://static.hindawi.com/articles/bri/volume-2013/251752/figures/251752.fig.005b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Cyclin D expression</td></tr></table></td></tr></table>

<table>Effect of Escin on the expression of cyclin D in Panc-1 cells. (a) Western blot analysis. (b) Densitometry results averaged from 3 independent experiments.</table>

Biochemistry Research International

fig5

Figure 5

Figure 5: Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway 